Bone Biologics Corp (BBLG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | N/A | 24 | N/A | N/A |
| TOTAL | $N/A | $31 | $N/A | $N/A |
| Non-Current Assets | ||||
| TOTAL | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $N/A | $31 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 1,717 | 386 | 0 | 0 |
| Other current liabilities | 253 | 193 | N/A | N/A |
| TOTAL | $13,692 | $578 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | N/A | 11,320 | N/A | N/A |
| TOTAL | $N/A | $11,320 | $N/A | $N/A |
| Total Liabilities | $13,692 | $11,899 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 12 | 31 | N/A | N/A |
| Retained earnings | -68,865 | -67,040 | N/A | N/A |
| TOTAL | $-13,692 | $-11,868 | $N/A | $N/A |
| Total Liabilities And Equity | $0 | $31 | $0 | $0 |